1Coveney E C, Geraghty J G, Sherry F,et al. Clinical valued CEA and CA 15-3 in breast cancer management[ J]. Int J Biol Markers, 1995,10( 1 ) :35-41.
2Buffaz P D, Gauchez A S, Caravel J P, et al. Can tumor marker msays be a guide in the prescription of bone scan for breast and lung cancers[J] .Eur J Nucl Med,1999,26(l) :8-11.
3Francini G, Montagnani M, Petrioli R, et al. Comparison between CEA,TPA, CA 15-3 and hydmxyprollne, alkaline phosphatase, whole body retention of 99mTc MDP in the follow-up of bone metastases in breast cancer[J] .Int J Bid Markers, 1990,5(1):65-72.
